$TRUMY News
Last published 3y ago
- 3y agoTRUMYTYO:4543Terumo Prospective Registry Reinforces Safety, Efficacy and Efficiency of Radial Access in Visceral Interventions (R.A.V.I.) in Embolization ProceduresPR Newswire– Findings show intra-vascular access via the radial artery can successfully be used as the primary strategy for the modern embolization practice – SOMERSET, N.J., March 13, 2023 /PRNewswire/ -- Terumo Medical
- 4y agoTRUMYTYO:4543New Randomized Controlled Study Published in JAMA Demonstrates the Value of Clinical Decision Support Tools in Preventing Acute Kidney Injury in Patients Undergoing Coronary AngiographyPR Newswire– Researchers used Terumo Health Outcomes' ePRISM® software to calculate safe contrast volume targets and improve overall patient outcomes – SOMERSET, N.J., Nov. 1, 2022 /PRNewswire/ -- A new study published in
- 4y agoTRUMYTYO:4543MicroVention Celebrates 25 Years in Neuroendovascular Technologies that Improve Patient LivesPR NewswireALISO VIEJO, Calif., Sept. 29, 2022 /PRNewswire/ -- MicroVention, Inc., a global neurovascular company and a wholly owned subsidiary of Terumo Corporation, celebrates its 25-year anniversary on September 29, 2022. Founded in 1997 by a handful of Associat
- 4y agoTRUMYTYO:4543MicroVention Announces First Patient Enrolled in the STRAIT Study with the New BOBBY™ Balloon Guide CatheterPR NewswireALISO VIEJO, Calif., April 20, 2022 /PRNewswire/ -- MicroVention, Inc., a wholly owned subsidiary of Terumo Corporation, announced the successful completion of its first enrollment in a multi-center, prospective EU observational study called STRAIT, to e
- 4y agoTRUMYTYO:4543Terumo Establishes Group-wide 'DE&I Philosophy' to Further Cultivate a Diverse, Equitable and Inclusive CulturePR NewswireTOKYO, Feb. 28, 2022 /PRNewswire/ -- Terumo Corporation (TSE: 4543) today announced that it has established a global "DE&I Philosophy" to further cultivate the culture of Diversity, Equity, and Inclusion (DE&I) at the Terumo Group. Additionally, a "DE&I
- 4y agoTRUMYTYO:4543Terumo and Corazon Sign Collaboration and Co-Marketing AgreementPR NewswireSOMERSET, N.J., Feb. 25, 2022 /PRNewswire/ -- Terumo Health Outcomes, a division of Terumo Medical Corporation, a leading global medical device manufacturer, has signed a collaboration and co-marketing agreement with Corazon, Inc., a leader in providing
- 4y agoTRUMYTYO:4543MicroVention Announces First U.S. Patient Treated with FRED™ X™ Flow Diverter Featuring X TechnologyPR NewswireALISO VIEJO, Calif., Feb. 22, 2022 /PRNewswire/ -- MicroVention, Inc., a subsidiary of Terumo and a global neurovascular company, announced the first U.S. clinical case of its next generation Flow Diverter, the FRED X device, at Thomas Jefferson Universi
- 4y agoTRUMYTYO:4543Terumo Medical Corporation Applauds ACC/AHA/SCAI Decision to Designate Radial Access Class 1, Level of Evidence APR NewswireSOMERSET, N.J., Jan. 11, 2022 /PRNewswire/ -- Terumo Medical Corporation (TMC) applauds the publication of updated guidelines from the American College of Cardiology (ACC), American Heart Association (AHA) and the Society for Cardiovascular Angiography a
- 5y agoTRUMYTYO:4543Terumo Celebrates 100th Anniversary of Contributing to Society Through HealthcarePR NewswireTOKYO, Sept. 17, 2021 /PRNewswire/ -- Terumo Corporation (TSE: 4543), a global leader in medical technology, today celebrates its 100th anniversary. The company, based in Tokyo, boasts over 25,000 associates worldwide, providing products and service
- 5y agoTRUMYTYO:4543Terumo Blood and Cell Technologies and PhotonPharma Inc. announce collaboration to develop a novel cancer immunotherapyPR Newswire1 in 3 people will be diagnosed with cancer in their lifetime1 LAKEWOOD, Colo. and FORT COLLINS, Colo., Aug. 11, 2021 /PRNewswire/ -- Terumo Blood and Cell Technologies (Terumo), a medical device company specializing in a portfolio of technology, s
- 5y agoTRUMYTYO:4543Terumo and UMCU strengthen their partnership to develop solutions in Interventional OncologyPR NewswireLEUVEN, Belgium, July 20, 2021 /PRNewswire/ -- Terumo Europe and University Medical Center Utrecht (UMC Utrecht) announced today that they signed a Memorandum of Understanding (MoU) to recognize the longstanding partnership in the field of oncology. In t
- 5y agoTRUMYTYO:4543Terumo Introduces New AZUR™ Vascular Plug and PG Pro™ Peripheral Microcatheter Embolization SystemPR NewswireSOMERSET, N.J., July 14, 2021 /PRNewswire/ -- Terumo Medical Corporation (TMC) has announced today the introduction of its AZUR™ Vascular Plug, the first and only plug compatible with a microcatheter to occlude arteries up to 8mm in diameter. The newes
- 5y agoTRUMYTYO:4543Terumo Donates Additional USD 1 Million to Support the COVID-19 Solidarity Response Fund for WHOPR NewswireTOKYO, May 13, 2021 /PRNewswire/ -- As the world joins together to fight the ongoing battle against the COVID-19 pandemic, Terumo Corporation (TSE: 4543) has announced that the Terumo Group companies will collectively donate USD 1 million in cash to supp
- 5y agoCSLLYTRUMYTYO:4543Terumo Blood and Cell Technologies and CSL Plasma Announce Collaboration to Deliver New Plasma Collection PlatformPR NewswireLAKEWOOD, Colo. and BOCA RATON, Fla., April 19, 2021 /PRNewswire/ -- Terumo Blood and Cell Technologies and CSL Plasma today announce a collaboration to deliver a new plasma collection platform at CSL Plasma U.S. collection centers. A clinical trial